Amneal Pharmaceuticals, Inc. (AMRX)
Health Care ยท Pharmaceutical Preparations
Amneal Pharmaceuticals, Inc. (AMRX) is listed on Nasdaq, where its shares have traded since May 7, 2018. SentiSense covers Amneal Pharmaceuticals, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Chirag Patel is its chief executive officer. The company reports 8,500 employees, and its corporate website is www.amneal.com.
About Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 299 institutions reported holding AMRX, with 163.2 million shares worth $2.8 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Tpg GP a. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on AMRX
- AMRX sentiment: whether news and social coverage of Amneal Pharmaceuticals, Inc. leans bullish or bearish, and the stories driving it.
- AMRX ownership: all 299 reporting institutions, plus insider and congressional trades.
- AMRX financials: revenue, net income, operating margin and free cash flow by quarter and year.
SentiSense also tracks daily options readings for Amneal Pharmaceuticals, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Amneal Pharmaceuticals, Inc. do?
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland.
What sector is AMRX in?
SentiSense classifies Amneal Pharmaceuticals, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does AMRX stock trade?
Amneal Pharmaceuticals, Inc. (AMRX) is listed on Nasdaq, where its shares have traded since May 7, 2018.
Who is the CEO of Amneal Pharmaceuticals, Inc.?
Chirag Patel is the chief executive officer of Amneal Pharmaceuticals, Inc..